About usBagó Group (Argentina) has entered Russian pharmaceutical market in 2004 with the preparations for treatment of diabetes and thyroid gland diseases. Later Bagó and CHEMO Group joined to work together in the markets of Russia and CIS countries via their joint venture, called BC Pharma B.V.. Its Moscow Representative Office was established in 2008.
Bagó and CHEMO Groups have more than 1 bln USD total turnover, more than 8 thousand employees all over the world, 28 production capacities, about 5 hundred products in different therapeutic directions, science-research centers and representative offices in more than 30 countries all over the world.
At present the members of Bagó Group are the leading pharmaceutical manufacturers in Argentina and in the majority of LA countries. Bagó Group also includes such medicine manufacturers as Laboratorios Bagó, Quimica Montpellier, and Bio Profarma, which develops and produces bio-tech oncological and oncohematological products.
CHEMO joins the group of vertically integrated companies with the headquarters in Madrid, Spain. The Group carries all sectors of the pharmaceutical industry starting with the development of API´s and following by developing and distributing of final dosage forms. For more than 30 years already CHEMO has been trading pharmaceutical substances and is considered the leader in this sphere.
Nowadays BC Pharma B.V. has Medical Representatives in all the regions of Russia. The Company promotes the existing product portfolio in the pharmaceutical market, makes active preparations for participation in scientific-research and educational projects.
Bagó products are presented in Russia in the following directions:
- endocrinology
- gastroenterology
- antibacterial therapy
The products supply is held by ORFE Ltd., which cooperates with the majority of leading Russian national and regional distributors.
To learn more about Bagó and Chemo, please, follow the links: www.bago.com, www.chemogroup.com. |
Русский
